Robyn Karnauskas

Robyn Karnauskas

Analyst-Equity presso
Centiva Capital LP
Finance
Consumer Services

Profilo

Robyn Karnauskas is currently a Senior Biotechnology Analyst at Centiva Capital LP, starting in 2025.
Former positions include Analyst at Truist Securities, Inc. from 2019 to 2025; Large Cap Biotech Analyst at Citigroup Global Markets, Inc. (Broker) from 2015 to 2019; Vice President at Deutsche Bank Securities, Inc. from 2010 to 2015; Principal at Deutsche Bank Securities, Inc. from 2008 to 2010; Principal at Morgan Stanley & Co., Inc. (India) in 2010; Research Analyst at Bear, Stearns & Co., Inc. from 2004 to 2008; Senior Associate at Sterling Financial Investment Group from 2004 to 2005.
Education includes undergraduate studies at Massachusetts Institute of Technology and a doctorate from The University of Chicago.

Posizioni attive di Robyn Karnauskas

SocietàPosizioneInizio
Analyst-Equity 01/04/2025

Precedenti posizioni note di Robyn Karnauskas

SocietàPosizioneFine
Analyst-Equity 01/02/2025
Analyst-Equity 01/06/2019
Analyst-Equity 01/10/2015
Corporate Officer/Principal 01/06/2010
Corporate Officer/Principal 01/05/2010
Vedi nel dettaglio l'esperienza di Robyn Karnauskas

Formazione di Robyn Karnauskas

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

96

Relazioni di 1° grado

9

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private9

Finance

Finance

Finance

Finance

Finance

Finance

Consumer Services

Finance

Finance

  1. Mercati
  2. Insiders
  3. Robyn Karnauskas